155 related articles for article (PubMed ID: 8540031)
21. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
[TBL] [Abstract][Full Text] [Related]
22. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
23. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
24. T-cell restriction patterns in pig bone marrow chimera.
Nakajima K; Ochiai T; Suzuki T; Gunji Y; Ohta M; Isono K; Sachs DH
Transplant Proc; 1996 Jun; 28(3):1244-5. PubMed ID: 8658642
[No Abstract] [Full Text] [Related]
25. Depletion of accessory cells strongly reduces immunogenicity of T-depleted bone marrow, and thus may facilitate its engraftment.
Dreger P; Steinmann J; Löffler H; Müller-Ruchholtz W
Transplant Proc; 1989 Feb; 21(1 Pt 3):2949-51. PubMed ID: 2523164
[No Abstract] [Full Text] [Related]
26. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
27. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers.
Sosnová M; Bradl M; Forrester JV
Stem Cells; 2005 Apr; 23(4):507-15. PubMed ID: 15790772
[TBL] [Abstract][Full Text] [Related]
28. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
[TBL] [Abstract][Full Text] [Related]
29. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
[TBL] [Abstract][Full Text] [Related]
30. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
31. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
32. Retrovirus-mediated transfer and expression of swine MHC class II genes in CD34+ monkey stem cells.
Banerjee PT; Ierino F; Kaynor GC; Giovino M; Sablinski T; Emery DW; Rosa MD; LeGuern C; Sachs DH; Monroy RL
Transplant Proc; 1996 Apr; 28(2):747-8. PubMed ID: 8623378
[No Abstract] [Full Text] [Related]
33. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
[TBL] [Abstract][Full Text] [Related]
34. Human vertebral body bone marrow harvest: comparison between manual and automated methods.
Bottino R; Linetsky E; Selvaggi G; Kong SS; Qian T; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3340. PubMed ID: 8539981
[No Abstract] [Full Text] [Related]
35. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
[TBL] [Abstract][Full Text] [Related]
36. Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
Siena S; Bregni M; Gianni AM
Exp Hematol; 1993 Feb; 21(2):203-5. PubMed ID: 7678809
[No Abstract] [Full Text] [Related]
37. Antigenic characteristics of normal and malignant human hematopoietic cells. Potential use of antigenic differences in cell separation and marrow transplantation.
Cline MJ; Fitchen JH; Foon K; Billing R
Exp Hematol; 1979; 7 Suppl 5():246-51. PubMed ID: 400688
[TBL] [Abstract][Full Text] [Related]
38. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
Kwekkeboom J; Buurman DE; Ploemacher RE; Baars JW; Loos HA; Slaper-Cortenbach IC
Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
[TBL] [Abstract][Full Text] [Related]
39. The AIS CELLector: a new technology for stem cell purification.
Okarma T; Lebkowski J; Schain L; Harvey M; Tricot G; Srour E; Meyers WG; Burnett A; Sniecinski I; O'Reilly RJ
Prog Clin Biol Res; 1992; 377():487-502; discussion 503-4. PubMed ID: 1279717
[No Abstract] [Full Text] [Related]
40. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
